FlexCath AdvanceRecalls & reported problems across all models
Medtronic, Inc. · 6 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 350
- Deaths reported
- 14
- Injuries reported
- 147
- Recalls
- 0
We found 6 models of FlexCath Advance by Medtronic, Inc. in the FDA's device registry (GUDID). Together they are named in 350 adverse event reports in the FDA's MAUDE database, received between Dec 7, 2016 and Apr 6, 2026 — classified as 14 deaths, 147 injuries, 189 malfunctions.
The most frequently reported specific device problem is “Material Twisted/Bent” (69 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
Most reported FlexCath Advance problems
Device problems
- Adverse Event Without Identified Device or Use Problem152
- Material Twisted/Bent69
- Gas/Air Leak55
- Fluid/Blood Leak27
- Compatibility Problem25
- Air Leak20
- Material Integrity Problem16
- Peeled/Delaminated12
Patient problems
- No Clinical Signs, Symptoms or Conditions102
- Pericardial Effusion74
- No Known Impact Or Consequence To Patient71
- Low Blood Pressure/ Hypotension48
- Cardiac Tamponade27
- Cardiac Perforation20
- No Consequences Or Impact To Patient16
- No Code Available11
FlexCath Advance models
6 models, most reported first. Each model has its own page with its reports, recalls and device details.
- FlexCath Advance™ 4FC12CATHETER, STEERABLE6 deaths167 reports
- FlexCath Advance™ 4FC12CATHETER, STEERABLE4 deaths61 reports
- FlexCath Advance™ 4FC12CATHETER, STEERABLE4 deaths60 reports
- FlexCath Advance™ 4FC12CATHETER, STEERABLE59 reports
- FlexCath Advance™ 990065CATHETER, STEERABLE2 reports
- Flexcath® Advance 4FC12CATHETER, STEERABLE1 report
Recent FlexCath Advance adverse event reports
The 15 most recent reports across all models, in the reporter's own words as published by the FDA.
InjuryApr 6, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT, DURING A CARDIAC ABLATION PROCEDURE, "PERICARDIAL HEMORRHAGE" OCCURRED DURING ATRIAL SEPTAL PUNCTURE. EMERGENCY PERICARDIOCENTESIS WAS PERFORMED. THE PROCEDURE WAS ABORTED. THE HOSPITALIZATION WAS EXTENDED FOR 3 DAYS. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Pericardial Effusion
MAUDE report 24793010 ↗MalfunctionAug 22, 2025Material Twisted/Bent; Device Handling Problem; Material Twisted/Bent; Device Handling Problem
IT WAS REPORTED THAT DURING A PULMONARY VEIN ISOLATION PROCEDURE WITH CRYO ABLATION, AFTER SUCCESSFUL COMPLETION OF THE TRANSEPTAL P UNCTURE, THE PHYSICIAN NOTED THAT THE STEERING MECHANISM OF THE FLEXCATH ADVANCE SHEATH WAS BROKEN AND THERE WAS A STEERABILITY ISSUE. THE SHEATH WAS REPLACED. THE CASE WAS SWITCHED TO AND COMPLETED WITH PULSED FIELD ABLATION. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22870460 ↗InjuryAug 11, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A PULMONARY VEIN ISOLATION PROCEDURE USING THE CATHETER AFAPRO23 AFA PRO 23, THE PATIENT EXPERIENCED ST SEGMENT ELEVATION AFTER THE FIRST CRYO ABLATION IN THE LEFT INFERIOR PULMONARY VEIN. FREEZE PARAMETERS WERE NORMAL AT -63 DEGREES FOR 180 SECONDS, AND THE ONSET OF ST SEGMENT ELEVATION OCCURRED 2 MINUTES AND 45 SECONDS INTO THE FREEZE. INTERVENTIONAL CARDIOLOGY WAS CONTACTED, AND 10MG INTRAVENOUS VASODILATOR MEDICATION WAS ADMINISTERED. THE PROCEDURE WAS ABORTED UNDER GENERAL ANESTHESIA. CORONARY ANGIOGRAPHY REVEALED COMPLETED OCCLUSION OF THE RIGHT CORONARY ARTERY AND CHRONIC CORONARY ARTERY DISEASE IN THE LEFT MAIN/LEFT ANTERIOR DESCENDING ARTERIES. THE PATIENT EXHIBITED SMALL RUNS OF VENTRICULAR TACHYCARDIA AND PREMATURE VENTRICULAR CONTRACTIONS, WHICH WERE TREATED WITH 150MG OF AN ANTIARRHYTHMIC MEDICATION. AN INTERVENTIONALIST INJECTED 300MCG INTRACORONARY VASODILATOR MEDICATION INTO THE AORTIC ROOT/RIGHT CORONARY ARTERY, WHICH IMMEDIATELY RESOLVED THE ST SEGMENT ELEVATION. THE EVENT WAS DIAGNOSED AS ACUTE CORONARY SPASM. THE PATIENT WAS STABLE, TRANSFERRED TO THE INTENSIVE CARE UNIT FOR MEDICAL MANAGEMENT, AND UNDERWENT A COMPUTED TOMOGRAPHY SURG
Patient problems: Cramp(s) /Muscle Spasm(s); Non specific EKG/ECG Changes; Tachycardia
MAUDE report 22772134 ↗InjuryAug 5, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A PULSED FIELD ABLATION PROCEDURE, BEFORE THE ABLATION WAS COMPLETED AND THE CARDIOVERSION WAS PERFORMED, SIGNIFICANT BLEEDING WAS OBSERVED AT THE SLIDE CONTROL ON THE LOOP CATHETER HANDLE. THE PHYSICIAN EXPRESSED CONCERN DUE TO LOSS OF AIR TIGHTNESS AT THE HANDLE AND THE LOOP CATHETER WAS REPLACED AFTER THE PATIENT'S CARDIOVERSION, AND POTENTIAL INSPECTION AND SUPERIOR CAVITY POTENTIAL ABLATION WERE PERFORMED. THE PROCEDURE WAS COMPLETED WITH CRYOABLATION. DUE TO LOSS OF AIR TIGHTNESS, THE PHYSICIAN WAS CONCERNED PATIENT MAY HAVE CAUSED AN AIR EMBOLISM. A MAGNETIC RESONANCE IMAGING (MRI) BRAIN WAS COMPLETED POST OPERATIVELY. THE PATIENT REQUIRED EXTENDED HOSPITALISATION. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT. (B)(6) 2025 IT WAS FURTHER REPORTED THAT THE MRI SHOWED LACUNAR INFARCTION. (B)(6) 2025 IT WAS LATER REPORTED THAT THE CASE WAS COMPLETED WITH PULSED FIELD ABLATION.
Patient problems: Air Embolism; Ischemia Stroke
MAUDE report 22715320 ↗MalfunctionJul 22, 2025Material Twisted/Bent; Device Handling Problem; Material Twisted/Bent; Device Handling Problem
IT WAS REPORTED THAT DURING A PULSE ABLATION PROCEDURE, THE SHEATH SUDDENLY COULD NOT BE BENT. REPEATED TROUBLESHOOTING WAS PERFORMED, BUT THE ISSUE COULD NOT BE RESOLVED. THE SHEATH WAS REPLACED, WHICH RESOLVED THE ISSUE. THE CASE WAS COMPLETED WITH PULSED FIELD ABLATION. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22567073 ↗MalfunctionJul 1, 2025Material Twisted/Bent; Material Twisted/Bent
IT WAS REPORTED THAT DURING A CARDIAC ABLATION PROCEDURE, THE SHEATH TIP BECAME KINKED AND COULD NOT BE USED. THE SHEATH WAS REPLACED. THE CASE WAS COMPLETED WITH CRYO. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22369088 ↗InjuryJun 4, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A CARDIAC ABLATION PROCEDURE, AFTER THE ATRIAL SEPTUM WAS PUNCTURED AND THE ADJUSTABLE CURVED SHEATH WAS INTRODUCED INTO THE LEFT ATRIUM, THE BALLOON CATHETER WAS ADVANCED IN PREPARATION FOR CRYOABLATION. AT THIS POINT, THE PATIENT EXPERIENCED A RAPID DROP IN BLOOD PRESSURE, WEAKENED HEART CONTRACTION, AND CONVULSIONS. DS IMAGING WAS USED AND IDENTIFIED PERICARDIAL TAMPONADE. RESUSCITATION EFFORTS INITIATED, AND PERICARDIOCENTESIS WAS PERFORMED, WITH MORE THAN 100 ML DRAINED. THE PATIENT REQUIRED MORE THAN 2 HOURS OF RESUSCITATION AND WAS SUBSEQUENTLY STABILIZED AND TRANSFERRED TO THE INTENSIVE CARE UNIT FOR MONITORING AND TREATMENT. THE PROCEDURE WAS ABORTED, AND NO ABLATION WAS PERFORMED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Cardiac Tamponade; Low Blood Pressure/ Hypotension; Pericardial Effusion
MAUDE report 22139635 ↗InjuryJun 3, 2025Compatibility Problem; Adverse Event Without Identified Device or Use Problem; Compatibility Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A CRYO ABLATION PROCEDURE, THE SURGEON PERFORMED AN ATRIAL SEPTAL PUNCTURE. SINCE THE OUTER SHEATH DIAMETER OF THE ADJUSTABLE CURVED CATHETER SHEATH WAS 15F, IT WAS DIFFICULT TO DELIVER AFTER ENTERING INTO THE FEMORAL VEIN. THE SURGEON DECIDED TO USE A BLADE TO DILATE THE SKIN OF THE PATIENT'S FEMORAL VEIN. DUE TO THE PATIENT'S ANATOMY, THE BLADE SCRATCHED THE FEMORAL ARTERY, CAUSING THE PATIENT TO BLEED CONTINUOUSLY. AT THIS TIME, CORRESPONDING RESCUE MEASURES WERE TAKEN AND THE PATIENT WAS OBSERVED FOR TWO HOURS. THE PATIENT WAS OUT OF DANGER AND TRANSFERRED TO THE WARD FOR CONTINUOUS OBSERVATION. THE CASE WAS ABORTED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 22132736 ↗InjuryApr 4, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT AFTER A CRYO ABLATION PROCEDURE, POST-PROCEDURE THE PATIENT EXPERIENCED SEVERAL ADVERSE EVENTS. POST PROCEDURE THE PATIENT EXHIBITED INFLAMMATION DUE TO PERICARDITIS. THE PATIENT LATER PRESENTED TO THE EMERGENCY DEPARTMENT (ED) WITH TACHYCARDIA ARRIVING WITH A HEART RATE IN THE 140S. THE PATIENT WAS MILDLY HYPOTENSIVE. THE PATIENT WAS PLACED ON A SALINE BOLUS AND A CALCIUM BLOCKER MEDICATION WAS ADMINISTERED. THE PATIENT WAS ELECTRICALLY CARDIOVERTED TO NORMAL SINUS RHYTHM AND DISCHARGED FROM THE ED. TWO DAYS LATER THE PATIENT RETURNED TO THE ED WITH IRREGULAR HEARTBEAT IN THE 130S AND 140S. THE PATIENT AS EXAMINED AND IT WAS OBSERVED THAT THE PATIENT HAD A DISTINCTLY REGULAR RHYTHM WITH RAPID HEARTBEAT. AN ELECTROCARDIOGRAM (EKG) TEST CONFIRMED ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE. PRIOR TO ADMINISTRATION OF A CALCIUM BLOCKER, THE PATIENT RETURNED TO NORMAL SINUS RHYTHM AND WAS DISCHARGED HOME. THREE DAYS LATER THE PATIENT RETURNED TO THE ED WITH PALPITATIONS AND SHORTNESS OF BREATH. A BETA BLOCKER WAS ADMINISTERED TO THE PATIENT WITHOUT RESOLUTION FOR THE ATRIAL FIBRILLATION. ANTIARRHYTHMIC MEDICATION WAS ADMINISTERED TO THE PATIENT. THE PATIEN
Patient problems: Arrhythmia; Atrial Fibrillation; Dyspnea; Low Blood Pressure/ Hypotension
MAUDE report 21773670 ↗InjuryMar 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A CARDIAC ABLATION PROCEDURE INVOLVING BOTH CRYOABLATION AND RADIOFREQUENCY, THE PATIENT EXPERIENCED VENTRICULAR FIBRILLATION (VF) ARREST. INITIALLY, THE PULMONARY VEINS WERE ABLATED USING CRYOABLATION. IT WAS NOTED THE PATIENT'S OXYGEN SATURATIONS HAD DROPPED DURING THE LAST FREEZE. THE PATIENT THEN HAD RADIOFREQUENCY WITH ANOTHER MANUFACTURER'S CATHETER TO ABLATE THE POSTERIOR WALL. PATIENT THEN EXPERIENCED AN EXTREMELY LOW RHYTHM WHICH PROGRESSED TO VENTRICULAR FIBRILLATION. RESUSCITATION MEASURES, WHICH INCLUDED CARDIOPULMONARY RESUSCITATION (CPR) AND EXTERNAL SHOCKS WERE CARRIED OUT. THE PATIENT WAS ADMITTED TO THE INTENSIVE CARE UNIT. IT WAS FURTHER NOTED PATIENT HAD SUSTAINED FRACTURED RIBS, POSSIBLY RELATED TO THE CHEST COMPRESSIONS. THE PROCEDURE WAS COMPLETED USING BOTH CRYO AND RADIOFREQUENCY WITH ANOTHER MANUFACTURER'S CATHETER. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Bone Fracture(s); Bradycardia; Low Oxygen Saturation; Ventricular Fibrillation
MAUDE report 21692112 ↗InjuryFeb 19, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS LATER REPORTED THAT THE CASE WAS COMPLETED WITH CRYO.
Patient problems: Chest Pain; Dyspnea; Pericarditis
MAUDE report 21409934 ↗InjuryDec 10, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A PROCEDURE, THE PATIENT EXPERIENCED HYPOTENSION PRIOR TO THE INSERTION OF THE SHEATH. THE PATIENT DEVELOPED A PERICARDIAL EFFUSION AND CARDIAC TAMPONADE. BASELINE IMAGING WAS OBTAINED TO ASSESS FOR PERICARDIAL EFFUSION PRIOR TO THE PROCEDURE. A PERICARDIOCENTESIS WAS PERFORMED TO ADDRESS THE EFFUSION AND TAMPONADE, WHICH RESULTED IN SYMPTOM RESOLUTION PRIOR TO LEAVING THE LAB. THE CASE WAS ULTIMATELY ABORTED WHILE THE PATIENT WAS UNDER GENERAL ANESTHESIA. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Cardiac Tamponade; Low Blood Pressure/ Hypotension; Pericardial Effusion
MAUDE report 20891842 ↗InjuryDec 6, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING THE INSERTION OF A CRYOBALLOON INTO THE LEFT ATRIUM, A THROMBUS WAS OBSERVED ON THE SHEATH AT THE RIGHT ATRIAL SEPTUM AFTER TRANSSEPTAL CROSSING. THE CASE WAS ABORTED BEFORE ANY CRYOTHERAPY DELIVERY. DESPITE ASPIRATION ATTEMPTS, THE THROMBUS REMAINED VISIBLE ON INTRACARDIAC ECHOCARDIOGRAPHY (ICE). A TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) WAS PERFORMED, AND THE PATIENT WAS TREATED WITH ANTICOAGULANT MEDICATION. THE PATIENT'S HOSPITALIZATION WAS EXTENDED FOR MONITORING. THE PROCEDURE WAS ABORTED, AND THE PATIENT WAS UNDER GENERAL ANESTHESIA. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Thrombosis/Thrombus
MAUDE report 20869781 ↗InjuryOct 30, 2024Adverse Event Without Identified Device or Use Problem; Device Handling Problem; Adverse Event Without Identified Device or Use Problem; Device Handling Problem
IT WAS REPORTED THAT DURING A CRYO ABLATION PROCEDURE, THE PATIENT EXPERIENCED A PERICARDIAL EFFUSION. IT WAS FURTHER REPORTED THAT THE ACCESS TO THE LEFT ATRIUM WAS LOST AND WHEN THE PHYSICIAN ATTEMPTED TO REGAIN ACCESS, THE PATIENT EXPERIENCED A DROP IN BLOOD PRESSURE. A PERICARDIAL EFFUSION WAS FOUND ON INTRACARDIAC ECHOCARDIOGRAPHY (ICE). A PERICARDIOCENTESIS WAS PERFORMED AND A DRAIN WAS LEFT IN THE PATIENT. THE PATIENT WAS TRANSFERRED TO THE HOSPITAL FLOOR AND HOSPITALIZATION WAS EXTENDED. IT WAS NOTED THAT NEITHER A DILATOR, NEEDLE, NOR A GUIDEWIRE WERE USED IN THE ATTEMPT TO REGAIN TRANSSEPTAL ACCESS. ADDITIONALLY, THE PHYSICIAN ALLEGED THAT A TAMPONADE CONTRIBUTED TO THE PERICARDIAL EFFUSION. THE CASE WAS ABORTED WHILE THE PATIENT WAS UNDER GENERAL ANESTHESIA. THE PATIENT HAS BEEN DISCHARGED TO HOME. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: Cardiac Tamponade; Pericardial Effusion
MAUDE report 20566069 ↗DeathOct 23, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A CRYO ABLATION PROCEDURE, THE PATIENT HAD HYPOTENSION, PERICARDIAL EFFUSION, AND CARDIAC TAMPONADE. THE CASE WAS ABORTED WHILE THE PATIENT WAS UNDER GENERAL ANESTHESIA. A PERICARDIOCENTESIS WAS PERFORMED AND THEN THE PATIENT EXPIRED. THE CAUSE OF DEATH WAS SURMISED TO BE PERICARDIAL EFFUSION AND CARDIAC TAMPONADE.
Patient problems: Bradycardia; Cardiac Tamponade; Low Blood Pressure/ Hypotension; Pericardial Effusion
MAUDE report 20515164 ↗
Other Medtronic, Inc. products
- CapSureFix Novus MRI SureScan29 models · 87,337 reports
- Medtronic Sprint Quattro Lead67 models · 45,880 reports · 1 recall
- Intellis AdaptiveStim3 models · 35,469 reports
- SYNCHROMED II11 models · 32,260 reports · 4 recalls
- CAPSUREFIX NOVUS17 models · 27,547 reports
- INTERSTIM30 models · 24,415 reports · 1 recall
- Sprint Quattro Secure S MRI SureScan7 models · 23,549 reports
- Medtronic LINQ Heart Monitor11 models · 19,366 reports · 3 recalls
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page